Elevated circulating levels of tissue factor in polycystic ovary syndrome

Clinical and Applied Thrombosis/Hemostasis

Volumn 19, Issue 1, 2013, Pages 66-72

  González, Frank ^a   Kirwan, John P ^b   Rote, Neal S ^c   Minium, Judi ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; blood coagulation factors; hyperandrogenism; thrombosis

Indexed keywords

ANDROSTENEDIONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRASTERONE SULFATE; TESTOSTERONE; THROMBOPLASTIN;

ABDOMINAL OBESITY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERANDROGENISM; INSULIN SENSITIVITY; LEAN BODY WEIGHT; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; THROMBOSIS;

ADULT; ANDROSTERONE; FEMALE; HUMANS; HYPERANDROGENISM; OBESITY, ABDOMINAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE; THROMBOPLASTIN; THROMBOSIS;

EID: 84871578360     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029612436673     Document Type: Article

References (39)

1. March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010 ; 25 (2). 544-551
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004 ; 81 (1). 19-25
3. Goodarzi MO, Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril. 2002 ; 77 (2). 255-258
4. Nestler JE, Jakubowicz DJ, de Vargas AF, et al. Insulin stimulates testosterone biosynthesis by human theca cells from women with polycystic ovary syndrome by activating its own receptor and using inositoglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998 ; 83 (6). 2001-2005
5. Freeman MS, Mansfield MW, Barrett JH, Grant PJ. Insulin resistance: an atherothrombotic syndrome. Thromb Haemost. 2003 ; 89 (1). 161-168
6. Mannerås-Holm L, Baghaei F, Holm G, et al. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011 ; 96 (6). 1068-1076
7. Talbott EO, Zborowski JV, Rager JR, et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004 ; 89 (11). 5454-5461
8. Vidal J, Gomis R. Interrelaciones entre obesidad y aterotrombosis. Rev Esp Cardiol Supl. 2008 ; 8 (suppl C). 3C - 11C
9. Hatakeyama K, Asada Y, Marutsuk K, Sat Y, Kamikubo Y, Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis. 1997 ; 133 (2). 213-219
10. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 1996 ; 94 (12). 3090-3097
11. Sprengers DE, Kluft C. Plasminogen activators and inhibitors. Blood. 1987 ; 69 (2). 381-387
12. Juhan-Vague I, Vague P. Hypofrinolysis and insulin resistance. Diabete Metab. 1997 ; 17 (1 pt 2). 96-100
13. Mertens I. Van Gaal LF Obesity, haemostasis and the fibrinolytic system. Obes Rev. 2002 ; 3 (2). 85-101
14. De Pergola G, De Mitrio V, Giorgino F, et al. Increase in both pro-thrombotic and antithrombotic factors in obese premenopausal women: relationship with body fat distribution. Int J Obes Relat Metab Disord. 1997 ; 21 (7). 527-535
15. Sawdey M, Podor TJ, Loskutoff DJ. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J Biol Chem. 1989 ; 264 (18). 10396-10401
16. Sotiriou SN, Orlova VV, Al-Fakhri N, et al. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J. 2006 ; 20 (3). 559-561
17. Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dandona P. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr. 2004 ; 80 (1). 51-57
18. Sampson M, Kong C, Patel A, Unwin R, Jacobs SJ. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clin Endocrinol. 1996 ; 45 (5). 623-629
19. Orio F, Palomba S, Cascella T, et al. Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?. Reprod Biomed Online. 2004 ; 9 (5). 505-510
20. Velazquez EM, Mendoza SG, Wang P, Glueck CJ. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1 lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome. Metabolism. 1997 ; 46 (4). 454-457
21. Atiomo WU, Bates SA, Condon JE, Shaw S, West JH, Prentice AG. The plasminogen activator system in women with polycystic ovary syndrome. Fertil Steril. 1998 ; 69 (2). 236-241
22. Atiomo WU, Fox R, Condon JE, et al. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in polycystic ovary syndrome. Clin Endocrinol. 2000 ; 52 (4). 487-492
23. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care. 1999 ; 22 (9). 1462-1470
24. Kohrt WM, Kirwan JP, King DS, Staten MA, Holloszy JO. Insulin resistance of aging is related to abdominal obesity. Diabetes. 1993 ; 42 (2). 273-281
25. González F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 ; 91 (1). 336-334
26. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist to hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr. 1998 ; 67 (1). 44-49
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the ultracentrifuge. Clin Chem. 1972 ; 18 (6). 499-502
28. González F, Rote NS, Minium J, Kirwan JP. Hyperglycemia stimulates proatherogenic inflammation pathways in polycystic ovary syndrome. Fertil Steril. 2006 ; 86 (2 suppl). S450
29. González F, Rote NS, Minium J, Kirwan JP. Evidence of proatherogenic inflammation in polycystic ovary syndrome. Metabolism. 2009 ; 58 (7). 954-962
30. González F, Minium J, Rote NS, Kirwan JP. Hyperglycemia alters tumor necrosis factor release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005 ; 90 (9). 5336-5342
31. Ibanez L, de Zegher F. Ethenylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab. 2004 ; 89 (9). 1592-1497
32. Yildirim B, Sabir N, Kaleli B. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003 ; 79 (6). 1358-1364
33. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003 ; 112 (12). 1796-1808
34. McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular adhesion molecule-1. Circulation. 1999 ; 99 (17). 2317-2322
35. Zhu XD, Bonet B. Knopp RH. 17β-Estradiol, progesterone and testosterone inversely modulate low-density lipoprotein oxidation and cytotoxity in cultured placental trophoblast and macrophages. Am J Obstet Gynecol. 1997 ; 177 (1). 196-209
36. Johnson M, Ramey E, Ramwell PW. Androgen-mediated sensitivity in platelet aggregation. Am J Physiol. 1977 ; 232 (4). H381 - H385
37. Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol. 1995 ; 15 (5). 562-570
38. González F, Rote NS, Minium J, Kirwan JP. Increased activation of nuclear factor B triggers inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 ; 91 (4). 1508-1512
39. González F, Rote NS, Minium J, Kirwan JP. In vitro evidence that hyperglycemia stimulates tumor necrosis factor release in obese women with polycystic ovary syndrome. J Endocrinol. 2006 ; 188 (3). 521-529